Lacrifill®: a new dry eye treatment by Nordic Pharma

Dry eye is a common and widespread condition characterized by inflammation of the ocular surface and lacrimal glands, and a reduction in the quality and/or quantity of tears. To treat these specific symptoms, Nordic Pharma has launched Lacrifill®, a hyaluronic acid gel which is relying on SYMATESE LAB expertise in hyaluronic acids and SYMATESE DEVICE‘s know-how in delivery system.

Find out more about its application and how it works from Dr. John P. Fezza, Ophthalmologist in USA: